According to a recent study, Pseudomonas aeruginosa produces the metabolite adenosine, followed by tumor-infiltrating IFN-γ+ CD4+ and IFN-γ + CD8+ T cells, enhancing immune therapy response, and improving the efficacy of checkpoint blockade immunotherapy (Mager et al., 2020). This evidence concerns the gene CD8A and neoplasm.